AME Guide Grand Rounds January 2026 Session

Federal Aviation Administration
121 followers
2 Video Views·Feb 27, 2026
This Grand Rounds session provides updates to the AME Guide, focusing heavily on new disposition tables and forms for various cardiovascular conditions, as well as a name change for a diabetes summary sheet. Dr. Northrup also discusses improvements in the medical review process, noting that the average time from deferral to decision for "first pass" general reviews and drug and alcohol cases is now less than 30 days.
Okay, well good evening or good morning or whatever it happens to be in your part of the world.
Welcome to January Grand Rounds. I'm going to turn this over to Dr. Susan Northrup,
our Federal Air Surgeon, for the opening remarks. Dr. Northrup.
All right, I'll be quick because there's a lot of material tonight and Dr. Bender does a great job
presenting it. But let me welcome you to the actual, no kidding, January Grand Rounds as
opposed to the late December Grand Rounds. And I want to thank each and every one of you that's
been helping the pilots reflight their medicals. It is beginning to show real, real fruition
in speeding this whole process up for the AME and the airmen. So thank you very much.
For the last three months, the general review time from deferral to decision has been averaging less
than 30 days for the first pass folks. That means they've brought everything they need to you,
you've uploaded it in the system and we've arrived at a decision. That includes weekends
and holidays. So thank you very much. Another good news, the drug and alcohol first pass set
is also below 30 days for the last couple of weeks. So congratulations and thank you very much.
And without further ado, I hope you enjoy this evening's presentations. And of course,
we're always looking for suggestions. So Christy, back to you.
Thank you, Dr. Northrup. And I'd also like to say hello to Dr. Wyrick, our Deputy Federal Air
Surgeon. I see him on video as well. So hello, Dr. Wyrick. Next slide, please, Dr. Bendrick.
So why are you here tonight? We have lots of AME guide updates that Dr. Greg Bendrick,
one of our medical officers, is going to discuss with you. Our objectives are to discuss the new
disposition table and AASI for mitral valve disease. We're going to talk about new disposition
tables and the status summary for typical atrial flutter that's been treated with ablation.
We're going to discuss new disposition tables and CACIs for carotid or vertebral
artery stenosis, review the calcium scoring and or coronary CT angiography. We're going to talk
about some name changes to the diabetes or hyperglycemia status summary sheet, as well as
review the NF-1 AASI and what we've removed from that particular form. Next slide, please.
So without further ado, I'm going to turn this over to Dr. Greg Bendrick. Dr. Bendrick.
Greetings. Greetings. Thanks, Christy. I'm Dr. Bendrick, as mentioned, one of the medical
officers here at the Air Medical Certification Division at the Civil Airspace Medical Institute
in Oklahoma, where we're dealing with the snow and stuff. Although today we've had some
temperatures above freezing, so it's getting a little bit better out there.
And been here at the FAA since 2017, so about eight and a half years now.
And for the most of that time, I was full-time certification officer. About a year ago,
I took over my current position, which is that as a physician trainer. So hence,
one of the reasons I am here involved with this, as well as many other things in terms of training.
And then along with that, I perform quality assurance review on the physician side of the
house. Likewise, I still do my share of certification, still do my share of
physician of the day duties. And so I've probably talked to a number of you on the POD calls.
Before I came to FAA, I was a little over 16 years at NASA Dryden Flight Research Center out
in California on Edwards Air Force Base. It was the alternate landing site for the shuttle,
and we did a lot of good aeronautical research and airborne science there.
And the shuttle program went away and ended up coming here to FAA. Before NASA, I was three
years in the private sector. And then before that, a little over nine years in the U.S. Air Force,
which is where I did my training in both aerospace medicine and occupational medicine,
which are my board specialties. So tonight, we have a lot about cardiology and diabetes
that I've worked with primarily over the years here since coming to the FAA. So I guess that's
one of the reasons they asked if I could give the talk this evening. So without further ado,
we'll talk about the microvalve disease and in particular the ASI that we've now developed for
with microvalve disease, as with really, you know, with most of your valvular conditions of
the heart. When the condition is mild or something less trace, okay, you know,
then we typically will warn for that. Typically, if something is moderate, whether it's
or, you know, microregurg, microinsufficiency, aortic regurg, aortic stenosis, typically,
as a rule of the FAA, if it's moderate, we're going to follow that on special issuance.
And you'll echo in an office note from the cardiologist. And if it's severe, typically,
we're looking to deny at that point and looking for some sort of remediation. We will look at all
data, but really, if the condition is into a severe range, then we typically find that
aeromedical risk to be too high. So kind of in that paradigm, if you will, when we look at
specifically at microvalve disease and specifically microregurgitation, microinsufficiency. Now,
we at the FAA use those two terms interchangeably, regurgitation and insufficiency,
whether or not they're associated with mitral valve prolapse. And so, you know, just be aware
of that. Just as a side note, some of the folks have been around for a while or may be up to speed
on your cardiology history. You know, in the old days, there was a lot of mitral valve stenosis
that was associated with the rheumatic heart disease, which was all, you know, of course,
associated with a streptococcal infection of the throat, strep pharyngitis. And then with
over the years, the development of antibiotics that, you know, really, really reduced the
prevalence of not only the rheumatic heart disease, but also the mitral stenosis. We don't
seem to see that very much. We'll still see it from time to time, mitral stenosis. But really,
what we see much more commonly in this realm is the mitral regurg, mitral insufficiency,
often but not always associated with some degree of mitral valve prolapse. So, as I mentioned,
if we get that, and we got an echo, you guys get the echo, for some reason, maybe you heard
a murmur on exam. A lot of times, this will be picked up by the AME. And AMEs, you know, as you
all should, you listen to the heart with your stethoscope, with the earpieces actually in your
ears. And we've had a number where they get picked up. We've had some very interesting conditions
picked up by the AMEs stuff. And so, in any case, they get the echo, if it's mild or trace,
and they're asymptomatic, shortness of breath, palpitations, chest pain, dyspnea on exertion,
anything like that. Go ahead and issue them. It's a regular issuance. Please upload that echo
report and any other reports you have, and note all that in block 60. Okay. Now, when we get to
moderate, and for the AME, moderate and severe is pretty much the same. You got to send us the same
information on both cases, in both degrees. So, that's pretty straightforward. Our disposition
is going to be different. As I mentioned, for severe, it's probably going to be denied.
And for moderate, it's most likely, usually, going to be a special issuance. And so,
what we're going to want for moderate, of course, the echo report there, of course. We want a
detailed clinical progress note from the cardiologist, usually the one who ordered the
echo, or did it, and specifically addressing any symptoms, as well as how they interpret
any studies that have been performed, and whether they, you know, agree with the findings or not.
That can be very helpful, especially when we're at the point of moderate to severe,
or considering the possibility of denying, hearing what the, or reading what the cardiologist has to
say, can be really very helpful in that long. So, we want that. Now, because of mitral, you know,
the mitral valve, it's sitting there, you know, in between the left atrium and the left ventricle.
And so, if you've got regurgitation, insufficiency, and you've got backflow,
and stuff, there's a good chance you could be getting some dilation of the left atrium. And,
of course, you know, whenever we start getting dilated left atria, we're at risk of seeing
atrial arrhythmias, namely our good friends afib and aflutter. So, we're going to talk a
little bit more about that here in a minute. But we, bottom line is, for the moderate,
or moderate to severe, mitral regurg, mitral insufficiency, we do want a 24-hour holter with
that. Some people, you know, they'll call, you know, can we do a 14-day, you know, cardiac event
monitor, a ZEO patch, cardio key, whatever they get. And so, of course, you know, certainly more
data is always better, especially if you're looking for something that doesn't happen,
you know, all the time, and it's periodic, paroxysmal. Yeah, longer is better. All we
really require is the 24-hour holter. If they want to do something longer, that's fine. We're
definitely happy to see that. But then you must defer the exam. Now, if everything is in the
moderate range, and they're having no symptoms whatsoever, and the holter monitor is like
stone cold normal, can be, you know, used in a textbook of normal physiology, okay, that's a
good case where you can give us a call here at CAMI as a physician of the day, or you can call
your regional flight surgeon's office, and you've got all the data there, and it's all very
straightforward, all very boring. We like boring. Then we can most likely give you a verbal
authorization at that time. Ideally, particularly for the AME record for the prior exam,
you can scan and upload those reports, or have your staff scan and upload the reports,
and then we can see them here on our end. And so, you know, I'd be on the phone, and I'm looking at
reports, and looking at this, and, yeah, it's moderate, and this is fine, and that's fine,
and, you know, no other concerns, and, yeah, you know, the mitral valve insufficiency is moderate,
but then their, you know, aorta is dilated at 5.5 centimeters. Well, you know, well, that's a
problem. That's a whole different problem. You know, that sort of stuff. You know, we're looking
at the whole report, and, but if it's all straightforward, very boring, we can most
likely give you the verbal auth on that, and we'd just like to note, by the way, over the past year
or so, we've had, typically on Tuesdays, as most of you know, we hadn't been doing position of the
day call. Well, fortunately, our colleagues on the regions have been able to step up and do
the position of the day calls on Tuesdays and Thursdays, so that frees up then the CAMI folks
to do other things like, you know, drug and alcohol reviews and things like that, and so,
yeah, shout out to my colleagues there on the regions helping out with the actual POV call,
and so we're five days on that. Medical appeals, okay, we don't do it on Tuesdays. We surge and
stuff, but for the bread and butter stuff, and certainly all this, this is all general review,
the five days a week now availability on that, so that's a good thing, and like I said,
you can also have the option of calling the regional flight surgeon's office, and, you know,
this stuff, it's, you know, very straightforward and easy to take care of, and what we'll likely
do then is, for the moderate, put them on an AASI for the mitral valve insufficiency, so on
subsequent evaluations, then you'll be able to issue the pilot, their certificate,
you know, if everything's normal, they meet, you know, all the script.
Oh, one thing going back on that, but just to note on the POV calls or the regional flight
surgeon calls, if you upload the reports to the exam that you're doing and you haven't transmitted
the exam yet, but then we can't see those reports, okay, it's got to be transmitted before
we can see the reports, but as I mentioned, if you're the AME of the past exam, you know, it's
okay to upload the current reports to the past exam, that's okay, and then we can actually see
it here on our end, and then give you the verbal author, then you can transmit the current exam,
that's okay. If you're not the AME of record for the past exam, then you just got to tell us
if we can make a disposition on that, that's great, if we can't, then we're just going to
have to say you got to defer, we'll try to work it, turn that around as quick as we can.
Yeah, some of the reports where they say, for the AME side, if it's a mild to moderate,
then consider that moderate, and, you know, defer, or, you know, ideally, maybe give us a call.
Likewise here, as we go from to the severe category, if it's moderate to severe,
consider that severe. Now, on our end, we'll, you know, we're going to read that report very
carefully, we're going to be looking at numbers, some places are able to do various calculations,
some are not so much, depends on the machine they're using, and if it really looks like this
is really in the moderate range and stuff, okay, we'll treat it accordingly. If it really looks
like it's a severe, and they're kind of calling it moderate to severe, we're going to treat it
as severe. So, anyway, for the AMEs, mild to moderate equals moderate. If moderate to severe
equals severe, and then we'll deal with it on our end. So, speaking of severe, if they have,
if it's listed as severe insufficiency, severe regurge on the echo, or if they're having any
symptoms, they're having, you know, palpitations, chest pains, occasionally, you know, getting
short-winded when they go upstairs, you know, doc, I used to be able to, you know, go up the whole
flight, now I got to stop, you know, halfway up, like an oxygen break or something. Well, then,
yeah, that's, all bets are off, we got to, you got to defer that, we got to take a look at that,
and we're going to be looking at that a little bit more carefully.
The pretty, we, of course, we want all that, if it's severe, we really want the echo and
Holter monitor, for that matter, to be done within 12 months. So, when we're in their severe
range, we really need something current to look at and see exactly how we're going.
When all the dust settles, if it's kind of more moderate than severe, we may look at doing like
a six-month special issuance and then getting another echo and, you know, report from the
cardiologist at that point. However, if it's really severe, then we're going to deny,
and at that point, we're really looking that this, this aromedical risk be mitigated,
and that's basically going to be with an intervention, either a valve repair,
or nowadays, they go ahead and just do the microvalve replacement. So, whether it's repair,
replacement, we want to see that, that, you know, risk, that severity is decreased and lessened,
and then we could do that. Moving right along, I'm going to shift gears a little bit and talk
about, I referred to AFib, AFlutter earlier, and when I first came to the FAA, my knowledge on the
subject was that AFib pretty much equals AFlutter, and AFlutter equals AFib. So, we even use the
term AFibFlutter, and that's the way we look at it. So, if somebody had AFlutter, okay, blah, blah,
we always need to work upgrading, but it turns out I was demonstrating my need for further
education at that point, and I do that a lot, and I was graced with getting further education and
was told that there's actually this other subset of atrial flutter called typical AFlutter,
typical atrial flutter, T-A-F, if you want to think of it that way. And so,
typical AFlutter is a different beast. It's kind of like this little, from what I understand,
is a little bypass track that can lead to AFlutter. The electrophysiologists out there,
they're looking at an EKG with an AFlutter pattern. Based on the pattern of the EKGs,
they can say, yeah, this is a typical pattern, or it's an atypical or non-typical pattern,
stuff, in which case they'll take them usually to the EP lab. They'll do further testing in
the lab. They'll isolate the track and then ablate it, either radiofrequency or cryoablation,
however they do it. But when they do that, it seems they have a very low complication rate
and a very high success rate. And that's good. And they are then, the pilot, the patient is still,
is then cured of their typical AFlutter. And that's a good thing. Okay, so now in my limited
and warped brain, I guess, I think of it kind of as kind of like the inverse, almost like a
Wolf-Parkinson-White thing, where Wolf-Parkinson-White, of course, is more ventricular.
But similarly, you know, if they identify the condition, do the testing, go to the EP lab,
do the testing, and ablate it, then that likewise has a very high success rate and a very low
complication rate. So with the, you know, I kind of look at it like a typical AFlutter.
If it's been ablated, and it's been more than two years ago, and they're asymptomatic and no
medications required, nothing like that. We want you, the A and me, to have the pilot's
cardiologist fill out the typical AFlutter treated with ablation status summary that you see here on
the slide. And then we'll advance it. And we have that right here. It was, this worksheet was put
together specifically for this purpose. And basically, we want the cardiologist to say, yes,
this indeed was the diagnosis of typical AFlutter. Okay. And then the date of ablation, you know,
was it more than two years ago? We want a Holter monitor that was done no sooner than 90 days after
the ablation. Now, if the ablation was, you know, three years ago, and they did the Holter monitor,
you know, two and a half years ago, that's okay. We will accept that if the ablation was done more
than two years ago. No meds, no symptoms, no clinical concerns. They do all that. Everything's
on the left side there, the yes category in the white boxes, the clear boxes, like most of these
things that we've put together now with the FAA. Everything's yes. Good to go. Scan that sheet,
upload it to the exam, note that in block 60, and tell the pilot to have a nice flow. Okay.
Now, if it's less than two years ago, we still want the DCPN from the cardiologist. Of course,
we want the procedure report. The DCPN from the cardiologist, and a Holter monitor no sooner than
90 days after the event. And then we had some discussion about this. We really do want an echo
at this point, because we want to see kind of what the atria are looking like, and if there's
any valvular concerns, which can be associated with that. So, we want the, for this, we want
the AMA to defer on that, and then we'll make a decision on our end. If everything looks good,
chances are we're going to issue the regular issuance, letter of eligibility, regular issuance
with a warning for the condition, and no more. But we want to, we really need to review that on our
end, because if you go to row C here on the AME guide for the typical A flutter, if it's really
not typical A flutter, if it's something else, then it's basically in the AFib category. And
at that point, we want all the workup that we require for AFib. That's a different page in the
AME guide. We want the AFib, A flutter status summary, and all that, and then for the initial
defer on that. A lot of times we're able to do an AASI for the AFib, A flutter, but we need that
putting the sleep study and all that sort of stuff that goes with AFib. So key point there,
take-home point is that there is this entity called typical A flutter, and if it's ablated
and it's successful, then there's a good chance we don't have to follow it after that.
More than two years ago, fill out the, have the cardiologist fill out the summary sheet
and it's regular issuance. Less than two years ago, get the required reports, defer to us,
and typically we could turn that around pretty quickly. Okay. And let me demonstrate my
challenges here with technology. Okay. And that, okay, there we go. Okay. There we go. Okay.
So moving right along on the next level of our cardiovascular journey,
we now have a CACI for carotid or vertebral artery disease. So typically the pilot,
kind of like the echoes, you know, they'll come in with their report of the carotid ultrasound.
They got it for whatever reason. Now, if they got the carotid ultrasound because they had a TIA
or a stroke, okay, we're done. We got to go down that pathway. This does not apply to those
conditions. Okay. And also be aware, okay, you know, sometimes the diagnosis of the presenting
symptoms gets kind of downgraded to transient global amnesia or something like that. And it's
kind of like, no, if the ER doc thought it was a TIA, then that's what we're going with.
And we're going to do the neural work, but we'll take it from there. So just keep that in mind.
But if they haven't had any symptoms like that and somebody somewhere thought it was a good
idea to get a carotid ultrasound and they have less than 50% in their carotids, you know, and
or the vertebral arteries that they're doing there, less than 50%, either side, both sides together,
whatever, that's fine. We're good. So 49% or less, you know, otherwise known as less than 50%.
Okay. Then the, just verify that, make sure they're having no symptoms. And the other thing
is that they can't be on a DOAC or a NOAC, you know, Eloquiz, Pradaxa, Xarelto, can't be on it
whether it's for another condition or not. Okay. So if they're on that, this does not apply.
So, but if that's the case, 49% or less, have a nice flight. Tell us about it in block 60.
Upload the reports and issue the certificate, assuming, you know, there's no other conditions
going on. If it is 50 to 80%, or for the engineers out there, 50 to 79%,
less than 80%. And again, no history of TIA or stroke. They're not on anti-coagulation
in the formal sense of the word, either, you know, Eloquiz, Pradaxa, Xarelto, whatever, or Coumadin.
They're not on that. If they are on that or any symptoms and stuff, okay, this does not apply,
but they're not on any coagulation. It's okay for them to be on aspirin and or Plavix or
Effiant, Berlintia, any of the anti-platelet therapies. That's okay. The actual formal
anti-coagulation note is not okay for the CACI. That'll go into some other reports.
But we want a detailed clinical progress note, of course, from the treating physician,
whether it's a neurologist or not. And we want the imaging, okay, and the imaging to be the
ultrasound. If they get a CT angiogram, that's fine. If they get a magnetic resonance angiogram,
that's fine. We want that done, you know, within the previous year. And that's fine. We don't
require a CTA or an MRA, necessarily. We just require the imaging. Usually, it's going to be
an ultrasound. But no formal coagulation, only the anti-platelet therapy, no symptoms,
no history of TIA or stroke, less than 80%, but more than 50% or more than CACI. And we will have
the CACI worksheet right here. So as you can see, no symptoms. And we continue the CACI as long as
there's no significant increase in the stenosis that prompts any kind of change in treatment
or surveillance. So, you know, one year they're calling it, you know, maybe 50%. The next year,
they're calling it, okay, well, it's not quite 70%, maybe 60%. No change in treatment, no change
in surveillance, whatever. Okay, that's fine. But the minute where the treating physician is
talking about, well, we need to do this more frequently, or I'm going to refer you to the
neurosurgeon or the vascular surgeon to talk about, you know, surgery, or, you know,
we need to do something different now. Well, then that doesn't, CACI doesn't apply anymore.
Got it. We want all those reports, you know. But it's, likewise, if they've had surgery,
this does not apply until at least two years after the surgery. As I mentioned, 79% or less,
it's less than 50%, it's a regular issuance. And there are no formal anti-coagulation,
just the anti-platelet therapy. And they could be on dual anti-platelet therapy, that's okay,
that's fine. But no formal anti-coagulation. Then that's the CACI, and hopefully we make
that a little bit easier for folks going forward. Of course, ROCE, if it's 80% or more,
they're on formal anti-coagulation for any reason, whether it's for the vertebral stenosis or
anything else. Certainly, if the treating physician is recommending surgery, well, then,
you know, we're going to say, yeah, we really want you to get the surgery to mitigate the
aromedical risk, which is present if you don't have the surgery. And of course, if there's any
symptoms or history of TIA and CBA and stuff. And so we want that. And keep also in mind
that if they've got significant atherosclerosis in the carotid and or the vertebral arteries,
there's a good chance they've got significant atherosclerosis somewhere else. So we do want
a cardiovascular risk assessment, basically a clinical evaluation in the lab work. We don't
necessarily require a stress test just for carotid significant or severe carotid or vertebral
artery disease. But if the cardiologist thinks that's indicated, well, obviously, we're going
to want that also. So, but that's hopefully will help out with the carotid or vertebral artery
situation. Going to the next level, sort of like climbing Mount Everest here, we're going to,
the next base camp on our cardiovascular climb up the mountain. And this is the one,
I guess it's forcing itself on becoming one of my favorite topics. I talked about this in the Grand
Rounds last May, I guess in 2025. And it was in response to over the years, we've been seeing
pilots getting calcium scores and or coronary CT angiography. In the old days, like 10 years ago,
it was just calcium scores. But nowadays, they actually go to get screened with the coronary CTA
and then they'll do the calcium score with that. Okay, whatever, you know, we'll take what we get.
When AME have asked me, is this a medical, you know, evaluation, a medical test, something that
the AME or that the airman needs to report on their AME exam, you know, I would say yes, it is,
you know, a medical visit, if you will, even if it was, you know, a screening thing offered,
you know, when they read the billboard somewhere driving home. But like any test, you know,
we don't require a coronary calcium score for pilot risk assessment. Okay,
that's actually been discussed, but we don't do that currently. However, if the pilot gets one
done, as the old adage goes, if you ask the question, you know, you better be ready for the
answer. And the answer for the FAA side, and this differs from clinical medicine, but the answer
from the FAA side is, as you can see here on the screen on the under calcium score, if they're a
first or second class pilot, and their calcium score is over 400, we really, really want a
cardiac cath. Basically, we require a cardiac cath. We will accept the coronary CT angiogram,
but everybody listen up. We will accept that only if we get the coronary CT FFR with that.
And basically, it's FFR, fractional flow reserve, and it's a way that they can look at the flow
through the artery of the die, and see across the stenosis, and measure the flow and the pressure
before the stenosis, and the flow and pressure after the stenosis, and then they do a ratio of
the two. And so it's fractional flow reserve. And it's, you come up with a number between zero and
one, and the general consensus on the CT FFR is that if it's below 0.80, then that's considered
a significant drop, and that reflects an obstructive stenosis, an obstructive lesion.
Okay. Now, why do we insist on that if they go down the coronary CTA route? That's because,
okay, with an invasive cath, of course, they go in with a catheter, and they inject dye into the
arteries of the heart, and you see what you see. And also, if there's a significant obstruction,
you're in a position to insert a stent, if that's indicated, and revascularize the condition.
But with a coronary CT angiogram, it's a peripheral IV. The technician injects the
radioactive contrast through the peripheral artery, and then the CT scanner does its slices
and takes pictures that way. So it's helpful, but it's not the same thing as an invasive
cardiac cath. It sees some, it'll see the hard plaque with calcium, but it's the soft plaque
that kills you, as they say, and leads to the plaque rupture and often the sudden cardiac events.
And so it'll see some of that, but it won't necessarily see it all. And so the coronary
CTA is just, it's really, that's all it is, meant to be, is a screening test and stuff.
Now, what they can do with that data, though, is that they can do the FFR
based on the CT data, based on the flow. Here's the problem, okay? Most,
virtually all of your coronary CTA facilities can't do CT FFR, okay? So what they got to do
is send it to another entity, a company, that all they do is CT FFR. They do the measurements and
send it back to whoever sent them the data. Sometimes the data, they just can't run it on,
and they'll say that, but most of the time they can do CT FFR. Yes, there is a fee for this.
There's a charge for this. And insurance companies typically have fairly specific
clinical criteria under which they'll pay for the CT FFR. So somebody's going to end up getting
a bill for this, and usually that's going to be the pilot. And so there's a little bit of a
logistical hurdle there in getting the CT FFR. But if they get the CT FFR, and if it's all
shown to be non-obstructive, i.e. 0.80 or above, we will accept that. We're still going to follow
them, but we'll accept it. I'm hitting CT FFR kind of hard because we say we will accept an
invasive cath or coronary CTA with CT FFR. What the pilots hear is, we will accept an invasive cath
or a coronary CTA. They don't hear the CT FFR part. And then, so they send that in, and we say,
well, okay, that's not sufficient. We really need an invasive cath or a CTA with the CT FFR.
The other thing, and I may be a little biased here, but the fact is, is that you see obstruction
on your CT FFR. Well, now you've got to go to the cath lab and get that revascularized.
If you're in the cath lab already for the initial test, you're already there,
and they can get it revascularized. Most of the time, they can get it revascularized. Sometimes
they end up needing bypass, but a lot of times they can put in one or more stents. And then,
you know, you wait the three months, you get the post-event cath, the stress test,
all that usual stuff. And the pilot usually can get back to flying that much sooner.
We go through the CT FFR, then they got to get the, you know, the thing, and then they got to
get the cath and then wait while they're just push that back, push back that much further.
And as an aside, the data has shown that if your calcium score is over 400,
your risk of major adverse cardiac events, which is presenting to medical attention with
angina or chest pain, myocardial infarction, or sudden cardiac death, which is a pretty hard
end point, the risk of those things within the year or certainly over the several years following
is really not trivial. And it's just aromatically unacceptable. And these are sudden or subtle
incapacitating events. And so if you're a professional pilot, basically first or second
class certificate holder, and your score is over 400, you're at an aromatically,
unacceptably high risk until that gets mitigated. So that's what we've been doing for a while.
We presented that at the Grand Rounds last May. And then we, now this is going to be
officially put into the AME guide. So if the insurance companies say, well, we're not going
to pay for a cath, then you can say, well, hey, this is an FAA requirement for this professional
pilot. Now, so that's kind of generated a lot of discussion, but it's amazing how many times we see
significant severe disease. I mean, they're like one platelet away from, you know, their left
anterior descending becoming the widowmaker. And, you know, they get the thing and they get the cath
and, you know, life is good. I'm still waiting for the shower of letters thanking us for saving
their lives. But anyway, I won't hold my breath. But it's good. You know, I mean, it's good medicine.
It's a good thing to do from aerospace medicine perspective. Now, if it's between 100, from above
100, but up into and including 400, all we require is a nuclear exercise stress test. We call it an
RS, radionuclide stress test. So that's what RS means. Of note though, even if they're third class
and their score, certainly if it's over 400, but even if it's 100 or 400, we will ask for the new
stress test because a lot of times the plane stress test just doesn't give you the information.
It's the electrical tracings are non-interpretable due to bundle branch block or artifact, whatever.
And this is a non-trivial risk. And so we do insist on nuclear stress test with that.
If they're under 100, that's fine. The risk is acceptable and you can issue the certificate
with that. You can see the parameters over on the coronary CTA side on the right side of the
chart here. But that doesn't seem to generate for some reason as much discussion as the simple
calcium score. Now, let's say they get it done. The CTFFR shows no obstruction and stuff. Well,
that's good. But chances are, we are still going to follow them except with some really
rare circumstances. We're going to follow them on either an AASI or ASI for the coronary artery
disease. Sometimes we'll require periodic stress testing. Usually we won't. So hopefully that helps
clarify things that'll be going into the, or it's already in the AME guide now as of this afternoon.
So that's that. One thing just for, was it semantic purposes? Our sheet for diabetes
was labeled diabetes on oral medications. And we'd get calls from time to time, you know,
on POD call. This guy, he's now on Ozempic, or he's now on, you know, Wigoby, you know,
whatever. And of course those are injectable medications. So can I still use, you know,
can I still do the ASI? Can I still use Worksheet? The answer is yes. Our big concern is insulin,
whether it's third class or whether it's first or second. And the concern there is, of course,
you know, hypoglycemia and its cognitive effects. For the non-insulin injectables and the oral
medications, much, much less frequent issues with hypoglycemia. And so we're okay with those
generally using that combination of sheets that's in the AME guide, combination of med
on the sheet in the AME guide. But we've changed the Worksheet then to just say
diabetes or hyperglycemia on medications. If it's insulin is the medication,
whole different workflow and we go down that. But that's, we just clarified that,
that it doesn't have to be oral per se. And then finally here, for all those folks
who see pilots with neurofibromatosis type 1, I'm being a little sarcastic, not a lot, but
we do see them. We see everything here. But anyway, we see neurofibromatosis. In the past,
we would require an IE valve and it would be an SI. But now we've changed that to the ASI without,
we don't require the IE valve each year, just the detailed clinical progress note
from the neurologist. We'd like it to be current, which is means within 90 days.
And we just want to verify that they're not having any new symptoms, signs, any new diagnosis,
no significant progression of disease, but we no longer require the IE valve at that point.
And with that, I am done. Yeah, I will wait for the applause to die down that now that I'm done
speaking and, but be happy to answer questions if they have any, or I'll turn it over to Christy.
As always, we just like to remind you that if you have suggestions for
AME guide improvement, you can send an email to ameguide at fa.gov. Keep in mind that this box
does not answer case questions, but I do know that the folks that work on the AME guide have
been working really hard to improve it just in the year, a little over a year and a half that
I've been with the team. So I believe that is the last slide. Dr. Northrup or Dr. Warrick,
would either of you like to say anything before we close out? Sure. You might've noticed a note
in the chat. Today is the 40th anniversary of the space shuttle Challenger disaster.
We learned a lot in the space program based on the investigation of that incident, but please take a
moment of your time to just think about them and the things that we learned and the people that
lost their lives in that incident. Further, tomorrow is the one year anniversary of the
Washington National Midair. If you haven't had a chance to take a look at the NTSB
report, lots to be learned from that incident as well. Thank you, ma'am. Okay. If you are not an
FAA employee, this concludes our session of Grand Rounds. Please go ahead and log yourself out.
For those of you that are FAA employees, stand by and we'll be going into the breakout room for the
debrief. Thank you all for joining us. Thank you for being in AME and thank you for your
commitment to aviation safety.
